←
OncoLens547 posts
OncoLens avatar

OncoLens

@OncoLens

OncoLens drives timely, precision cancer care through AI driven informatics and digital collaboration tools.

◷ Joined March 2017▧ 169 Photos and videos
OncoLens avatar
OncoLens@OncoLens·25 Oct 2024

"OncoLens' focus on not just delivering insights but usability tools such as provider targeted alerts, continues to excite us along with their already impressive growth." Mark Buffington, @bipventures We're thrilled to be part of the B group..the Series B group. We count our lucky stars by the number of cancer patient lives we can touch and we look forward to achieving even more major milestones alongside our wonderful customers. Link: oncolens.com/news/oncology-h…

Post attachment
OncoLens avatar
OncoLens@OncoLens·Nov 13

Inside: • 12 use cases across clinical care, research and trials, operations and finance, and patient access and equity • 5 readiness stages between the raw record and any decision • A one-page scorecard that rates your program from 0 to 4 on each

OncoLens avatar
OncoLens@OncoLens·Nov 13

It comes from roundtable discussions with health system, life sciences, patient advocacy and federal leaders, and it's built for cancer service line leaders and data and AI officers.

OncoLens avatar
OncoLens@OncoLens·Nov 13

Cancer programs do not have a data collection problem. They have a data use problem. @CancerXMoonshot and OncoLens built the Oncology Data Use Framework to answer a hard question: what can a cancer program actually do with the data it already holds?

Post attachment
OncoLens avatar
OncoLens@OncoLens·10 Oct 2024

Join us at the @ACCCBuzz Annual NOC Conference Stop by Booth 623 and learn how The OncoLens Research Network offers relevant, highly curated industry-sponsored initiatives, like clinical trials and disease-specific QIP’s, including innovative programs targeted to improve biomarker testing compliance to guidelines. We look forward to seeing you this week!

Post attachment
Stephen V Liu, MD avatar
⟳ OncoLens retweeted
Stephen V Liu, MD@StephenVLiu·8 Aug 2024

It's critical to wait for biomarker results before starting treatment for lung cancer - how do we balance that with the urgency to start treatment quickly? Advice from patient advocate Aurora Lucas & Drs. Mark Kris & @TurgemanIlit in this @IASLC podcast. iaslc.org/iaslc-news/lung-ca…

OncoLens avatar
OncoLens@OncoLens·11 Jul 2024

New Study on the Benefits of Cancer Survivorship Care @TimMullettMD, thoracic surgeon at @UKMarkey and chair of the @AmColSurgCancer (#ACS) Commission on Cancer (#CoC), co-authored a groundbreaking study on the value of cancer survivorship care standards. This research underscores the importance of structured care programs for cancer survivors, aiming to enhance their quality of life and long-term health outcomes. The study highlights: - Improved patient outcomes with standardized care - The need for comprehensive follow-up plans - Strategies for integrating survivorship care into clinical practice and multidisciplinary collaboration Read more about this significant advancement in cancer care: Markey physician co-authors study on value of cancer survivorship care standards: uknow.uky.edu/research/marke… and the full study here - JAMA Network Open: jamanetwork.com/journals/jam… #SurvivorshipCare #MultidisciplinaryCancerCare #HealthcareInnovation #MedicalResearch

.@TimMullettMD @UKMarkey explores research on cancer survivors. With the number of adult cancer survivors in the U.S. expected to reach 23 million by 2032, the long-term needs of this population are growing, yet often poorly understood and addressed. uknow.uky.edu/research/marke…

ACCC avatar
⟳ OncoLens retweeted
ACCC@ACCCBuzz·27 Jun 2024

There is still time to register for the final session of the Project ECHO tele-mentoring series on bispecific antibodies and care coordination. Earn 1.0 CME, CPE, or CNE credit when you complete the session. Register now at bit.ly/3wno9cx. Powered by @OncoLens

Post attachment